ibuprofen tablet, film coated
denton pharma, inc. dba northwind pharmaceuticals - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see wa
betmiga
astellas pharma europe b.v. - mirabegron - urinary bladder, overactive - urologicals - symptomatic treatment of urgency.increased micturition frequency and / or urgency incontinence as may occur in adult patients with overactive-bladder syndrome.
elaprase
takeda pharmaceuticals international ag ireland branch - idursulfase - mucopolysaccharidosis ii - other alimentary tract and metabolism products, - elaprase is indicated for the long-term treatment of patients with hunter syndrome (mucopolysaccharidosis ii, mps ii). heterozygous females were not studied in the clinical trials.
vpriv
takeda pharmaceuticals international ag ireland branch - velaglucerase alfa - gaucher disease - other alimentary tract and metabolism products, - vpriv is indicated for long-term enzyme-replacement therapy (ert) in patients with type-1 gaucher disease.
sotacor
pharmacy retailing (nz) ltd t/a healthcare logistics - sotalol hydrochloride 10 mg/ml - solution for injection - 40mg/4ml - active: sotalol hydrochloride 10 mg/ml
finasteride teva tablets 5mg
teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - finasteride - film-coated tablet - finasteride 5 mg - urologicals
firmagon
ferring pharmaceuticals a/s - degarelix - prostatic neoplasms - endocrine therapy - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer.- for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.- as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
modigraf
astellas pharma europe b.v. - tacrolimus - graft rejection - immunosuppressants - prophylaxis of transplant rejection in adult and paediatric, kidney, liver or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult and paediatric patients.
tractocile
ferring pharmaceuticals a/s - atosiban (as acetate) - premature birth - other gynecologicals - tractotile is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.
advagraf 0.5mg modified-release capsules
astellas pharma ltd - tacrolimus monohydrate - modified-release capsule - 500microgram